急性卒中诊疗与院内死亡的城乡差异
基于美国全国住院患者样本2012至2017年数据,回顾性分析792 054例急性卒中住院患者。农村患者静脉溶栓和血管内治疗使用率低于城市,院内死亡率更高,且五年间差距未缩小。
要点
- 农村急性缺血性卒中患者静脉溶栓使用率4.2%,城市为9.2%。
- 农村患者血管内治疗率1.63%,城市为2.41%。
- 农村卒中院内死亡率6.87%,城市为5.82%,且随农村程度增加而升高。
核心结论
- 农村卒中患者接受静脉溶栓或血管内治疗的可能性低于城市患者,且院内死亡率更高,这些差距在2012至2017年间未改善。
研究设计与样本
- 回顾性队列研究,使用2012至2017年美国全国住院患者样本数据,按居住县采用国家卫生统计中心6层分类方案划分农村程度。
主要发现
- 样本共792 054例急性卒中住院,农村患者较城市患者更常为白人(78%对49%)、年龄大于75岁(44%对40%)和最低收入四分位(59%对32%)。
- 急性缺血性卒中患者中,农村较城市静脉溶栓使用率更低(4.2%对9.2%,调整OR 0.55,95%CI 0.51-0.59,P<0.001),血管内治疗使用率也更低(1.63%对2.41%,调整OR 0.64,95%CI 0.57-0.73,P<0.001)。
- 总体卒中死亡率农村高于城市(6.87%对5.82%,P<0.001)。
- 调整后院内死亡率随农村程度增加而升高:郊区OR 0.97(95%CI 0.94-1.0,P=0.086)、大城镇OR 1.05(95%CI 1.01-1.09,P=0.009)、小城镇OR 1.10(95%CI 1.06-1.15,P<0.001)、小都市农村OR 1.16(95%CI 1.11-1.21,P<0.001)、偏远农村OR 1.21(95%CI 1.15-1.27,P<0.001)。
- 农村较城市患者的死亡率调整OR从2012年1.12(95%CI 1.00-1.26,P<0.001)至2017年1.27(95%CI 1.13-1.42,P<0.001),未见改善。
临床怎么用
- 应关注农村卒中患者静脉溶栓和血管内治疗的可及性差距。
- 改善循证卒中诊疗可及性可能是缩小城乡差异的靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The rural-urban life-expectancy gap is widening, but underlying causes are incompletely understood. Prior studies suggest stroke care may be worse for individuals in more rural areas, and technological advancements in stroke care may disproportionately impact individuals in more rural areas. We sought to examine differences and 5-year trends in the care and outcomes of patients hospitalized for stroke across rural-urban strata. METHODS: Retrospective cohort study using National Inpatient Sample data from 2012 to 2017. Rurality was classified by county of residence according to the 6-strata National Center for Health Statistics classification scheme. RESULTS: There were 792 054 hospitalizations for acute stroke in our sample. Rural patients were more often white (78% versus 49%), older than 75 (44% versus 40%), and in the lowest quartile of income (59% versus 32%) compared with urban patients. Among patients with acute ischemic stroke, intravenous thrombolysis and endovascular therapy use were lower for rural compared with urban patients (intravenous thrombolysis: 4.2% versus 9.2%, adjusted odds ratio, 0.55 [95% CI, 0.51-0.59], P<0.001; endovascular therapy: 1.63% versus 2.41%, adjusted odds ratio, 0.64 [0.57-0.73], P<0.001). Urban-rural gaps in both therapies persisted from 2012 to 2017. Overall, stroke mortality was higher in rural than urban areas (6.87% versus 5.82%, P<0.001). Adjusted in-patient mortality rates increased across categories of increasing rurality (suburban, 0.97 [0.94-1.0], P=0.086; large towns, 1.05 [1.01-1.09], P=0.009; small towns, 1.10 [1.06-1.15], P<0.001; micropolitan rural, 1.16 [1.11-1.21], P<0.001; and remote rural 1.21 [1.15-1.27], P<0.001 compared with urban patients. Mortality for rural patients compared with urban patients did not improve from 2012 (adjusted odds ratio, 1.12 [1.00-1.26], P<0.001) to 2017 (adjusted odds ratio, 1.27 [1.13-1.42], P<0.001). CONCLUSIONS: Rural patients with stroke were less likely to receive intravenous thrombolysis or endovascular therapy and had higher in-hospital mortality than their urban counterparts. These gaps did not improve over time. Enhancing access to evidence-based stroke care may be a target for reducing rural-urban disparities.
引用
- Hammond G, Luke AA, Elson L, et al. Urban-Rural Inequities in Acute Stroke Care and In-Hospital Mortality. Stroke. 2020. PMID: 32833593. doi:10.1161/STROKEAHA.120.029318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。